Skip to content

Cold Argon Plasma (CAP) Application in the Wound Treatment After Open Hemorrhoidectomy

Cold Argon Plasma Application in the Wound Treatment After Open Hemorrhoidectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03907306
Enrollment
100
Registered
2019-04-08
Start date
2018-09-01
Completion date
2021-03-31
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cold Argon Plasma

Keywords

Cold argon plasma, hemorrhoidectomy, wound healing, hemorrhoids

Brief summary

This is single-center, prospective, randomized study

Detailed description

This study will include patients with 3-4 stage hemorrhoids. They will undergo an operation of open hemorrhoidectomy. Patients will be divided into a study group and a control group. Study group patients during a post-operation period except a standard treatment (antiseptic solutions and antibacterial and wound healing ointments) of a post-operation wound will be treated with cold argon plasma. Control group patients will be treated with a standard treatment. Wound healing speed will be researched.

Interventions

PROCEDUREWound healing

The measurement of a wound area is committed on the 2nd, 8th, 14th, 21nd and 30th day after operation. By means of the mathematical formulas the wound healing speed will be defined. The wound process will be researched with the help of cytological method. The wound prints will be taken on the 2nd, 8th, 14th, 21nd and 30th day after operation. Microbiological research of a wound will be held on the 2nd, 8th, 14th, 21nd and 30th day after operation (in study groups before and after the usage of CAP, in control groups once). The pain assessment will be measured by a visual analogue scale on the 2nd, 3rd,4th, 5th, 6th, 7th, 8th, 14th, 21nd and 30th day after operation. The life quality will be researched by means of Health Status Survey on the 8th and 30th day before operation.

Sponsors

State Scientific Centre of Coloproctology, Russian Federation
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* 3-4 stage hemorrhoids * 3 hemorrhoids

Exclusion criteria

* patients underwent anal canals intervention * acute hemorrhoids * inflammatory bowel disease * co-morbidity diseases of anal canal and perianal area * concurrent conditions in the stage of decompensation

Design outcomes

Primary

MeasureTime frameDescription
Wound healing30 daysTotal wound healing will be assessed with the help of cytological and macroscopic methods.In the cytological method the presence of fibroblasts, mature epithelial cells, scar tissue formation and the absence of inflammation will be the criterion of wound healing, as well as the presence of macroscopic features of wound epithelialization.

Secondary

MeasureTime frameDescription
Pain Intensity Measure2, 3, 4, 5, 6, 7, 8, 14, 21, 30 daysVisual analogue scale (0-10 points)
Life qualitybefore operation, 8 days, 30 daysShort Form - 36 Health Status Survey
Microbiological contamination of wound area2, 8, 14, 21, 30 daysMicrobiological contamination from the post operation wound area. The assessment of CAP effect on bacteria in planktonic and biofilm forms. Microbiological research of a wound will be held on the 2nd, 8th, 14th, 21nd and 30th day after operation (in study groups before and after the usage of CAP, in control groups once).

Countries

Russia

Contacts

Primary ContactNikita V. Tuktagulov
dr.tuktagulov@gmail.com+7 926 188 31 29

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026